Business
Lucy Scientific Anticipates Sharp Losses Amidst Regulatory and Operational Costs
LOS ANGELES- Lucy Scientific Discovery Inc. has been in the spotlight, not for its recent acquisitions but for missing its annual report filing deadline with the U.S. Securities and Exchange Commission (SEC). While the company has kept its investors in the loop about anticipated losses, the official documents are expected to be filed by Oct. ...
Harvesting Opportunities Amid Seasonal Price Fluctuations
LOS ANGELES— Among decaying cornstalks and scarecrows, spanning 120 acres north of Paw Paw on County Road 665, stands a rich, green crop of lucrative trees — marijuana plants from Grasshopper Farms. In the cannabis industry, the annual October harvest, known as "Croptober", signifies the reaping of the state's outdoor marijuana crops. This season, Florida ...
New York Cannabis Licensing Resumes Amid Legal Controversies
NEW YORK — The Empire State today marked the opening of its general cannabis licensing window, despite the legal blockade on its Conditional Adult-Use Retail licensing program put in place by a judicial ruling in August. The current 60-day phase allows submissions for a spectrum of cannabis licensing, encompassing cultivators, processors, distributors, retailers, and micro ...
MJUnpacked Conference in Detroit: Where Retailers and Brands Meet Investors in Cannabis
DETROIT–Michigan is set to become the epicenter of the cannabis industry as the highly anticipated MJUnpacked Conference unfolds from October 10th to 12th, 2023. This distinctive event, organized by Jage Media, Inc., promises an exclusive gathering of nationwide license holders and accredited investors, providing a unique platform for networking, collaboration, and strategic planning. An Exclusive ...
PharmaTher Holdings Pursues Ketamine-Based Medical Product, Eyes Global Market After FDA Nod
LOS ANGELES- In a recent development marking a leap in the medical application of ketamine, PharmaTher Holdings announced that the U.S. Food and Drug Administration (FDA) accepted the Abbreviated New Drug Application (ANDA) for its KETARX ketamine product. The target date for this priority original ANDA, under the 2022 Generic Drug User Fee Amendments (GDUFA), ...
Navigating the Green Wave: Key Considerations for Cannabis Operators in Company-Wide Restructuring
LOS ANGELES- The cannabis industry has experienced unprecedented growth and transformation in recent years, driven by changing regulations and shifting consumer attitudes. As the market matures, cannabis operators are increasingly looking to streamline operations, improve efficiency, and position themselves for long-term success. One crucial strategy in achieving these goals is company-wide restructuring. However, this process ...
Cybin Inc. Advances in Psilocybin Research with Completion of Phase 2 Study Enrollment
LOS ANGELES- Cybin Inc. (CYBN) announced the successful enrollment completion in its Phase 2 study of CYB003, a novel deuterated psilocybin analog, which is being assessed for potential treatment benefits in Major Depressive Disorder (MDD). The final, sixth cohort of the study has seen participants receive either a placebo or a 16mg dose of CYB003. ...
Enveric Biosciences Attains Landmark US Patent for Psilocybin-Derived Mental Health Treatments
LOS ANGELES- In a significant stride towards revolutionizing treatments for mental health disorders, Enveric Biosciences disclosed that it has secured a pivotal patent from the United States Patent and Trademark Office. Granted on September 12, 2023, the U.S. Patent No. 11,752,130 titled "Carboxylated Psilocybin Derivatives and Methods of Using," pertains to Enveric's developing EVM301 Series ...
Cannabis Stocks Surge Amidst Favorable Regulatory Signals
NEW YORK, NY–In recent days, cannabis stocks have been on an upward trajectory, buoyed by positive regulatory developments. This rally has sparked optimism among investors, particularly in the Canadian Licensed Producers (LPs) and U.S. Multistate Operators (MSOs) segments. The resurgence began following reports of a leaked letter from the U.S. Department of Health and Human ...
Canopy Growth Foresees Strengthened Financial Position with $50 Million Private Placement
LOS ANGELES– In a significant move underscoring its commitment to fortifying its financial foothold, Canopy Growth Corporation, a player in the North American cannabis and consumer packaged goods sector, announced on Monday its entry into subscription agreements for a private placement offering. Strategic Financial Maneuver In an announcement made through a press release dated September ...
Columbia Care Advances Financial Strategy with $25 Million Private Placement
NEW YORK - Columbia Care Inc., a cultivator, manufacturer, and retailer of cannabis products in the U.S, has embarked on the next stage of its strategy to enhance its balance sheet, commencing with a private placement agreement to improve its financial stability and pave the way for further growth. A Structured Financial Initiative The New ...
Revitalization of Cannabis Industry through Amsterdam-Style Social Cafes
LOS ANGELES- In an effort to revitalize the state's cannabis industry and bolster tourism in dormant urban areas, California assemblymember Matt Haney (D-San Francisco) has introduced legislation that may potentially reshape the existing cannabis marketplace. AB 374, a proposed bill that garnered substantial bipartisan support, seeks to empower local governments to license cafes where people ...
Maine’s Recreational Cannabis Sector Flourishes
LOS ANGELES- In the state of Maine, the burgeoning adult-use cannabis sector is witnessing a significant uptick in sales, reaching a pinnacle in August with revenues exceeding $21 million, as per data released by the state's Office of Cannabis Policy. This surge is a testament to the steadily growing market, which is poised to eclipse ...
Anticipating the Green Rush: New York Sets the Stage for Cannabis Expansion
NEW YORK - In a pivotal move, the New York Cannabis Control Board has greenlit a comprehensive set of regulations that lays the foundation for a significant expansion of the Empire State's burgeoning cannabis industry. The regulations, enthusiastically approved by the Cannabis Control Board, meticulously detail the licensing and operational protocols for various facets of ...
Benzinga Cannabis Capital Conference Unites Industry Titans and Advocates in Chicago
CHICAGO–Benzinga Cannabis Capital Conference, the world's largest and most successful cannabis investing and finance event, will return to Chicago on Sept. 27-28, 2023, at the Magnificent Mile Marriott in the heart of the Windy City. This year's event promises to be an extraordinary convergence of thought leaders, policymakers, advocates, and institutional investors at a time ...
New York Opens the Door for Established Cannabis Operators to Enter the Adult-Use Market
NEW YORK-- In a significant move that could reshape the cannabis landscape in New York, state regulators voted on Tuesday to permit existing medical cannabis operators to apply for adult-use retail licenses. This decision potentially positions these operators to dominate what is anticipated to be one of the largest markets on the East Coast. The ...
California Poised To Be Third U.S. State to Decriminalize Psychedelics
LOS ANGELES–California is poised to become the third state in the nation to decriminalize the use of psychedelics, following the State Assembly's recent approval of a bill. This legislation would grant individuals aged 21 and older the right to possess and utilize limited quantities of natural psychedelic substances like psilocybin (found in hallucinogenic mushrooms), dimethyltryptamine ...
Cannabis ETF MSOS Skyrockets Following HHS Rescheduling Recommendation; Valuations Surge
NEW YORK— The cannabis industry has witnessed unprecedented growth in recent years, and the latest surge comes on the heels of a groundbreaking announcement by the U.S. Department of Health and Human Services (HHS). The AdvisorShares Pure US Cannabis ETF (MSOS) experienced a meteoric rise, gaining an astounding 69.4% between August 25, 2023, and September ...
California Poised To Be Third U.S. State to Decriminalize Psychedelics
LOS ANGELES–California is poised to become the third state in the nation to decriminalize the use of psychedelics, following the State Assembly's recent approval of a bill. This legislation would grant individuals aged 21 and older the right to possess and utilize limited quantities of natural psychedelic substances like psilocybin (found in hallucinogenic mushrooms), dimethyltryptamine ...
Phoenix-Based Tilt Holdings Divests Stake in Shinnecock Nation Cannabis Partnership
LOS ANGELES-- In a strategic shift indicative of changing market dynamics, Tilt Holdings, a prominent Phoenix-based cannabis operator, has resolved to sever its ties with a cannabis partnership initiated with the Shinnecock Nation. A mere three weeks after divulging its intention to reassess the business arrangement, the firm has formally announced the sale of its ...
Otsuka Pharmaceutical Set to Acquire Mindset Pharma in C$80 Million Deal
TORONTO — Mindset Pharma Inc. based in Toronto, is set to be acquired by the Japan-based Otsuka Pharmaceutical Co. via its American subsidiary. This all-cash deal, announced Thursday, is valued at about C$80 million ($59.15 million). The terms of the agreement denote that for every share held, Mindset shareholders will obtain $0.75 in cash. This ...
Georgia Approves Three More Dispensaries for Medical Cannabis Program
ATLANTA — Georgia's Access to Medical Cannabis Commission (GMCC) has given the nod to three additional dispensary locations, augmenting the availability of low-THC oil products for patients across the state. During the public meeting on August 23, members of the GMCC unanimously approved these new locations. One of the giants in the cannabis industry, Florida-based ...
UK’s Home Office Delay in CBD Regulatory Framework Draws Criticism from Industry Trade Group
LONDON — The Association of the Cannabinoid Industry (ACI), a key trade group in the United Kingdom, has voiced its concerns over the prolonged delay by the country's Home Office in establishing a clear regulatory framework for cannabidiol (CBD) products. CBD, a non-psychoactive compound derived from the cannabis plant, has been available on U.K. store ...
Cybin Acquires U.K.-Based Small Pharma Amid Emerging Trends in Psychedelics Industry
NEW YORK — In what could be described as the burgeoning movements within the psychedelics sector, Cybin , a clinical-stage biopharmaceutical firm, has announced its intention to acquire U.K.'s Small Pharma. This move sparks dialogue on potential shifts and consolidations anticipated in the industry. Under the agreed terms, Small Pharma shareholders are set to receive ...
Evolving Cannabis Retail Landscape Sees Shifts in Billion-Dollar State Markets
LOS ANGELES — The U.S. cannabis industry, still in its nascent stages, witnessed notable shifts in 2023 with a projected reduction in states reaching the billion-dollar mark in retail sales, according to a comprehensive report by Cannabis Business Times. Eight states are expected to achieve this benchmark, down from nine in 2021. Traditional leaders like ...
